Skip to main content
Vivesto logo

Vivesto — Investor Relations & Filings

Ticker · VIVE ISIN · SE0000722365 LEI · 5493003TZPR4B7QO9L49 ST Manufacturing
Open in API
Filings indexed 1,074 across all filing types
Latest filing 2026-06-05 Board/Management Inform…
Country SE Sweden
Listing ST VIVE

About Vivesto

https://www.vivesto.com/en/

Vivesto is a specialty pharmaceutical company focused on drug development in oncology. The company aims to provide new therapeutic options for patients suffering from hard-to-treat cancers where significant medical needs exist. Its research and development efforts are centered on creating innovative treatments and enhancing the intravenous delivery of established and novel drugs. The company's lead product is Apealea, a formulation of the cancer drug paclitaxel.

Recent filings

Filing Released Lang Actions
Vivesto utser Björn Svanström till CFO
Board/Management Information Classification · 93% confidence The document is a press release announcing the appointment of a new CFO, detailing changes in senior management. This clearly fits the Board/Management Information category, which covers announcements of changes in the company’s board of directors or senior management roles.
2026-06-05 Swedish
Vivesto appoints Björn Svanström as CFO
Board/Management Information Classification · 95% confidence The document is a press release announcing the appointment of a new Chief Financial Officer, i.e., a change in senior management. This matches the definition for Board/Management Information (MANG).
2026-06-05 English
Major Shareholding Notification 2026
Major Shareholding Notification Classification · 92% confidence The document is a notification filed with the Swedish Financial Supervisory Authority (Finansinspektionen) disclosing a change in major shareholding (crossing the 5% threshold) by Avanza Bank Holding AB for its subsidiary. It follows the structure and legal references for a major shareholding notification, detailing share quantities, voting rights percentages, and transaction reason. This matches the Major Shareholding Notification category (Code: MRQ).
2026-06-02 English
New number of shares and votes in Vivesto
Share Issue/Capital Change Classification · 88% confidence The document is a press release announcing completion of a reverse share split (1:100) and the resulting new number of shares and votes. This is a corporate action affecting capital structure (share consolidation). Therefore, it falls under Share Issue/Capital Change.
2026-05-29 English
Nytt antal aktier och röster i Vivesto
Share Issue/Capital Change Classification · 95% confidence The document is a press release by Vivesto AB detailing a share consolidation (reverse split) of 100 shares into 1, reducing the total number of shares and votes. This constitutes a capital change event (stock consolidation), which falls under "Share Issue/Capital Change" (SHA).
2026-05-29 Swedish
Major Shareholding Notification 2026
Major Shareholding Notification Classification · 92% confidence The document is a notification filed under Swedish Finansinspektionen rules detailing a change in a major shareholder’s holdings of Vivesto AB shares, including before and after share counts and voting rights, and explicitly states 'Reason for major shareholding notification'. This matches the Major Shareholding Notification category.
2026-05-25 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.